We are live on ! Find out more
STJ

St Jude Medical
STJ

Delisted

STJ was delisted on the 4th of January, 2017.

563 hedge funds and large institutions have $15.3B invested in St Jude Medical in 2014 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 185 increasing their positions, 217 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 45

35% more call options, than puts

Call options by funds: $60.3M | Put options by funds: $44.7M

1% more funds holding

Funds holding: 555563 (+8)

11% less capital invested

Capital invested by funds: $17.2B → $15.3B (-$1.95B)

15% less repeat investments, than reductions

Existing positions increased: 185 | Existing positions reduced: 217

55% less funds holding in top 10

Funds holding in top 10: 115 (-6)

Holders
563
Holders Change
+8
Holders Change %
+1.44%
% of All Funds
16.34%
Holding in Top 10
5
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-54.55%
% of All Funds
0.15%
New
61
Increased
185
Reduced
217
Closed
45
Calls
$60.3M
Puts
$44.7M
Net Calls
+$15.6M
Net Calls Change
-$98.3M
Name Holding Trade Value Shares
Change
Change in
Stake
State of Wisconsin Investment Board
101
State of Wisconsin Investment Board
Wisconsin
$22.8M +$612K +9,370 +3%
Allianz Asset Management
102
Allianz Asset Management
Germany
$22.5M +$772K +11,822 +3%
MTB
103
Mizuho Trust & Banking
Japan
$22.3M -$5.51M -84,414 -19%
First Trust Advisors
104
First Trust Advisors
Illinois
$21.4M -$7.6M -116,288 -25%
APG Asset Management
105
APG Asset Management
Netherlands
$21.4M -$1.37M -20,951 -6%
Citadel Advisors
106
Citadel Advisors
Florida
$21.3M +$6.8M +104,157 +42%
AII
107
AGF Investments Inc
Ontario, Canada
$20.9M +$5.79M +88,700 +34%
HSBC Holdings
108
HSBC Holdings
United Kingdom
$20.8M -$18.7M -286,370 -45%
IG
109
ING Group
Netherlands
$20.4M -$8.96M -137,221 -29%
Credit Agricole
110
Credit Agricole
France
$18.9M +$9.73M +148,896 +90%
TA
111
Teachers Advisors
New York
$18.6M -$33.6M -514,481 -62%
Barclays
112
Barclays
United Kingdom
$17.7M +$5.4M +82,684 +39%
SCM
113
Stevens Capital Management
Pennsylvania
$16.8M +$18.3M +279,441 New
WBC
114
Westpac Banking Corp
Australia
$16.4M +$759K +11,619 +4%
Swiss National Bank
115
Swiss National Bank
Switzerland
$16.4M -$281K -4,300 -2%
SOMRS
116
State of Michigan Retirement System
Michigan
$15.6M +$216K +3,300 +1%
U
117
UBS
Switzerland
$15.6M -$4.4M -67,374 -21%
HCM
118
Highbridge Capital Management
New York
$15.6M +$16.9M +258,721 New
Fisher Asset Management
119
Fisher Asset Management
Washington
$15.4M -$310K -4,751 -2%
HSA
120
Hussman Strategic Advisors
Maryland
$15M
US Bancorp
121
US Bancorp
Minnesota
$15M -$134K -2,051 -0.8%
MVIP
122
Mar Vista Investment Partners
California
$14.7M -$739K -11,307 -4%
EVM
123
Eaton Vance Management
Massachusetts
$14.4M +$3.66K +56 +0%
HW
124
Hancock Whitney
Mississippi
$13.7M +$341K +5,218 +2%
AAM
125
Aberdeen Asset Management
United Kingdom
$13.6M -$311K -4,754 -2%

STJ Hedge Fund Activity: Q3 2014 in Review

563 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q3 2014, worth a combined $15.3B — down 11% from $17.2B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new STJ positions and 45 closed out — a net gain of 16 holders — while 185 added to existing stakes and 217 trimmed.

The largest buyer was Bank of America, adding an estimated $184M. The largest seller was Norges Bank, cutting an estimated $142M.

  • 563 institutional investors held St Jude Medical (STJ) as of Q3 2014, up from 555 in Q2 2014.
  • Funds reported $15.3B of St Jude Medical stock for Q3 2014, down 11% quarter-over-quarter.
  • 61 funds opened new St Jude Medical positions in Q3 2014 and 45 closed out, a net change of +16 holders.
  • The largest St Jude Medical buyer in Q3 2014 was Bank of America, an estimated $184M added.
  • The largest St Jude Medical seller in Q3 2014 was Norges Bank, an estimated $142M sold.

Based on aggregated 13F filings for Q3 2014.